Trulicity (dulaglutide) is a prescription drug that can cause weight loss in some people but is not approved for this use.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using ...

Check the Victoza medication guide for a full list of potential side effects. Trulicity is a GLP-1 agonist that helps manage type 2 diabetes and has shown to aid in weight loss. Clinical trials ...

The use of semaglutide (Ozempic) was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

GLP-1 receptor agonists were more cardioprotective in younger people, but reduced HbA1c more with age. The age of type 2 ...

A KKF poll finds that, overall, 12% of Americans have used or are using a GLP-1 agonist like Trulicity ... a year because of gastrointestinal side effects, the price tag, or perceived lack ...

While some people taking GLP-1 agonists experience difficult side effects, including nausea ... Dulaglutide is marketed by Eli Lilly under the brand name Trulicity for the treatment of type 2 diabetes ...

Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q4 2024 earnings call. [Operator instructions] I would now like to turn the conference over to your host, Mike Czapar, ...

Trulicity is another type of GLP-1 receptor ... the medications listed in this article may cause unwanted side effects and are not appropriate for everyone. It’s important to meet with a ...

Worldwide Trulicity revenue declined 25% ... which is to say that it mitigated tolerability concerns. So the GI side effects that are just known to this class seem to be significantly mitigated ...